NeuShen Therapeutics

Series-B+
neushen.com Biotech & Healthcare Shanghai, China 11-50
Total Funding $100M
Latest Round $80M Series-B+
Last Announced Sep 7, 2026
Investors 10 Backers
Decision Makers 5 Verified

About NeuShen Therapeutics

We are a global biotech company committed to developing new and effective therapies for psychiatric and neurological disorders affecting millions of patients in need.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Shanghai, China
Team Size 11-50
Tracked Since Oct 9, 2026

Web & Domain Identity

Official Website neushen.com
Domain Registered Date Jun 7, 2021

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $80,000,000 · Series-B

    Backed by B Capital, Legend Capital

  2. Capital Raise

    Raised $20,000,000 · Seed

    Backed by Lapam Capital, BioVenture

  3. Milestone

    Website domain registered

    neushen.com

Investors & Backers

10
B Capital
BioVenture
Lapam Capital
Legend Capital
Lilly Asia Ventures
Matrix Partners China
Pivotal bioVenture Partners
Qiji Investment
Shanghai Guotou Pioneer
TruMed Investment

Funding History

2 Rounds
Series-B equity · Sep 7, 2026

Round backers: B Capital, Legend Capital, Lilly Asia Ventures, Matrix Partners China, Shanghai Guotou Pioneer, TruMed Investment

Seed equity · Sep 29, 2022

Round backers: Lapam Capital, BioVenture

$20,000,000 prnewswire.com

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts